BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 30742783)

  • 1. Biomarkers of Acute and Chronic Kidney Disease.
    Zhang WR; Parikh CR
    Annu Rev Physiol; 2019 Feb; 81():309-333. PubMed ID: 30742783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical Markers of Renal Function.
    Krstic D; Tomic N; Radosavljevic B; Avramovic N; Dragutinovic V; Skodric SR; Colovic M
    Curr Med Chem; 2016; 23(19):2018-40. PubMed ID: 26769095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Kidney Injury: Tubular Markers and Risk for Chronic Kidney Disease and End-Stage Kidney Failure.
    Tan HL; Yap JQ; Qian Q
    Blood Purif; 2016; 41(1-3):144-50. PubMed ID: 26764483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of renal function, which and when?
    Wasung ME; Chawla LS; Madero M
    Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition.
    Lu M; Wang P; Qiao Y; Jiang C; Ge Y; Flickinger B; Malhotra DK; Dworkin LD; Liu Z; Gong R
    Redox Biol; 2019 Sep; 26():101275. PubMed ID: 31349118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal biomarkers and kidney disease progression after acute kidney injury.
    Wen Y; Xu L; Melchinger I; Thiessen-Philbrook H; Moledina DG; Coca SG; Hsu CY; Go AS; Liu KD; Siew ED; Ikizler TA; Chinchilli VM; Kaufman JS; Kimmel PL; Himmelfarb J; Cantley LG; Parikh CR;
    JCI Insight; 2023 May; 8(9):. PubMed ID: 36951957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression from acute kidney injury to chronic kidney disease: a pediatric perspective.
    Goldstein SL; Devarajan P
    Adv Chronic Kidney Dis; 2008 Jul; 15(3):278-83. PubMed ID: 18565478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of the transition from acute to chronic kidney injury following ischemia/reperfusion.
    Liu J; Kumar S; Dolzhenko E; Alvarado GF; Guo J; Lu C; Chen Y; Li M; Dessing MC; Parvez RK; Cippà PE; Krautzberger AM; Saribekyan G; Smith AD; McMahon AP
    JCI Insight; 2017 Sep; 2(18):. PubMed ID: 28931758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction and the AKI-to-CKD transition.
    Jiang M; Bai M; Lei J; Xie Y; Xu S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1105-F1116. PubMed ID: 33073587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNAs in kidney injury and repair.
    Liu Z; Wang Y; Shu S; Cai J; Tang C; Dong Z
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C177-C188. PubMed ID: 30969781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Injury Marker 1 and Neutrophil Gelatinase-Associated Lipocalin in Chronic Kidney Disease.
    Castillo-Rodriguez E; Fernandez-Prado R; Martin-Cleary C; Pizarro-Sánchez MS; Sanchez-Niño MD; Sanz AB; Fernandez-Fernandez B; Ortiz A
    Nephron; 2017; 136(4):263-267. PubMed ID: 27771693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix Metalloproteinase-10 in Kidney Injury Repair and Disease.
    Sun X; Liu Y
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
    Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
    Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular communication network factor 2 (CCN2) promotes the progression of acute kidney injury to chronic kidney disease.
    Inoue T; Kusano T; Amano H; Nakamoto H; Okada H
    Biochem Biophys Res Commun; 2019 Sep; 517(1):96-102. PubMed ID: 31320136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubular and Glomerular Biomarkers of Acute Kidney Injury in Newborns.
    Kamianowska M; Szczepański M; Wasilewska A
    Curr Drug Metab; 2019; 20(5):332-349. PubMed ID: 30907310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular trafficking of tubular MDM2 implicates in acute kidney injury to chronic kidney disease transition during multiple low-dose cisplatin exposure.
    Su H; Ye C; Lei CT; Tang H; Zeng JY; Yi F; Zhang C
    FASEB J; 2020 Jan; 34(1):1620-1636. PubMed ID: 31914692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in acute and chronic kidney disease.
    Nickolas TL; Barasch J; Devarajan P
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):127-32. PubMed ID: 18277143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response.
    Strausser SA; Nakano D; Souma T
    Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):314-322. PubMed ID: 29702491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward Precision Medicine: Exploring the Landscape of Biomarkers in Acute Kidney Injury.
    Nourie N; Ghaleb R; Lefaucheur C; Louis K
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanisms of Kidney Injury and Repair.
    Rayego-Mateos S; Marquez-Expósito L; Rodrigues-Diez R; Sanz AB; Guiteras R; Doladé N; Rubio-Soto I; Manonelles A; Codina S; Ortiz A; Cruzado JM; Ruiz-Ortega M; Sola A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.